Neurology Alert – December 1, 2004
December 1, 2004
View Issues
-
The Changing Face of Bacterial Meningitis
The mortality associated with bacterial meningitis remains high, and the strongest risk factors for an unfavorable outcome are those that are indicative of systemic compromise, a low level of consciousness, and infection with S. pneumoniae. -
Carotid Artery Plaque: Symptoms and Percent Stenosis Are Only Part of the Story
These results demonstrate a major role of carotid thrombosis and inflammation in ischemic stroke in patients affected by carotid atherosclerotic disease. -
Atherothrombosis and Atrial Fibrillation: Mixing Treatments to Match Pathophysiology
Current clinical trial evidence favors the use of aspirin or clopidogrel as first-line agents for the majority of patients with vascular disease. -
Porphyria, Neurology, and Neuropathy
The severity of the neuropathy and the availability of potential treatments, including avoidance of provocative factors, make identification important. -
Sudden-Onset Sleep in Parkinson’s Disease: Who is at Risk?
SOS, in part, can be attributed to PD-specific pathology because disease duration and subjective disease severity have been shown to be predictors of SOS. -
Chronic Immune Sensory Polyradiculopathy: A Possibly Treatable Sensory Ataxia
This condition preferentially affects large myelinated fibers of the posterior roots, may respond favorably to treatment, and may be a restricted form of chronic inflammatory demyelinating polyradiculoneuropathy. -
Pharmacology Watch: ACE Inhibitors and Receptor Blockers: Which is Inferior?
The first head-to-head comparison study of an ACE inhibitor and an angiotensin receptor blocker, to assess renoprotective effects in type 2 diabetes, has shown that the drugs are comparable in their benefit. -
Clinical Briefs in Primary Care Supplement